Dr. Reddy's Laboratories Limited Share Price and Company Fundamentals



Price
₹4394.35
Change
39.900 (0.916%)
52 week
3654.0 - 5614.6

Last traded: Today at 9:43 AM

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. Its Proprietary Products segment focuses on the research and development of differentiated formulations. The Others segment engages in developing therapies in the fields of oncology and inflammation. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Key Metrics

PE ratio

30.95

PB ratio

3.82

Dividend yield

0.69%

Beta

0.18

Market cap

-

Enterprise value

-

Company profile

Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Full time employees24795
Websitehttps://www.drreddys.com
Mailing address8-2-337, Road No. 3 Banjara Hills Hyderabad 500034 India
Phone / Fax91 40 4900 2900 / 91 40 4900 2999

Dividends

Dividend yield

0.69%

Dividend amount

₹30.00

Payout ratio

17.64%

5Y Avg. yield

0.68%

Dr. Reddy's Laboratories Limited paid ₹30.00 dividend and the ex-dividend date was 11 July 2022.The dividend payout ratio is 17.64%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.DRREDDY dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

DRREDDY's forward dividend amount is ₹30 and the forward dividend yield is 0.68%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Jul 2022, following are the company executives and directors listed on Dr. Reddy's Laboratories Limited.

NameTitleAgeTotal Pay
Mr. Gunupati Venkateswara Prasad B.E.Co-Chairman, MD & Member of Management Council61156.12M
Mr. Kallam Satish ReddyChairman & Member of the Management Council54105.35M
Mr. Erez Israeli M.B.A.CEO & Member of the Management Council53
Mr. Parag AgarwalCFO & Member of Management Council
Mr. Deepak Sapra M.B.A.CEO of API & Services & Member of Management Council46
Mr. Venkata Ramana Motupalli M.B.A., MBACEO of Branded Markets - India & Emerging Countries and Member of Management Council52
Ms. Archana Bhaskar B.Sc., M.B.A.EVP, Head of Corp. Communications, Chief HR Officer & Member of Management Council54
Mr. Sanjay Sharma B.Tech.Exec. VP, Global Head of Global Manufacturing & Member of Management Council53
Mr. Marc Kikuchi B.A., M.B.A.CEO of North America Generics & Member of Management Council52
Mr. Patrick Aghanian B.A., M.B.A.CEO of European Generics & Member of Management Council56

Profitability and management effectiveness

Profit margin

10.99%

Operating margin

16.75%

Return on assets

8.04%

Return on equity

12.96%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Dr. Reddy's Laboratories Limited is and its enterprise value is .

The DRREDDY's stocks Beta value is 0.18 making it 82% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Dr. Reddy's Laboratories Limited (NSE:DRREDDY) Frequently Asked Questions

1. What is Dr. Reddy's Laboratories Limited's Stock Symbol?

Dr. Reddy's Laboratories Limited trades on NSE under the ticker symbol "DRREDDY".

2. What is Dr. Reddy's Laboratories Limited's stock price today?

One share of DRREDDY stock can currently be purchased for approximately ₹4394.35.

3. How can I contact Dr. Reddy's Laboratories Limited?

Dr. Reddy's Laboratories Limited's mailing address is 8-2-337, Road No. 3 Banjara Hills Hyderabad 500034 India. The company can be reached via phone at 91 40 4900 2900.

4. What is Dr. Reddy's Laboratories Limited's official website?

The official website of Dr. Reddy's Laboratories Limited is https://www.drreddys.com.